50% of cancer patients abandon treatment due to financial constraints – Dr. Naa Adorkor Aryeetey

Dr. Naa Adorkor Aryeetey, a Senior Specialist in Oncology and Radiotherapy, has revealed that half of the patients diagnosed with cancer fail to return for further treatment, primarily due to financial difficulties and the psychological burden of living with the disease.

Speaking in an interview with Kwesi Kyei Darkwa (KKD) on CTV’s Master of the Game on Wednesday, November 27, 2024, Dr. Aryeetey highlighted the pressing challenges faced by cancer patients.

She explained that the financial strain of treatment and the trauma associated with a cancer diagnosis often deter many from seeking the care they need.

Defining cancer, Dr. Aryeetey described it as “the abnormal growth of cells that have the ability to spread to other parts of the body.”

She noted that there are two main types of cancer: benign, which is non-cancerous, and malignant, which is cancerous and can affect any part of the body.

She pointed out that the most common cancers affecting women are breast and cervical cancer, while prostate cancer is prevalent among men.

Dr. Aryeetey emphasized the importance of regular self-examinations and early detection, urging people to pay attention to unusual growths, swellings, or wounds that do not heal.

“Everyone must examine their body regularly for any changes,” she advised.

She expressed concern over the lack of organized cancer screening programmes in Ghana, which has led to doctors relying on opportunistic screening during unrelated medical visits.

Calling for a robust response to cancer care, Dr. Aryeetey urged the government to adhere to the World Health Organization’s guideline of allocating 15% of the Gross Domestic Product (GDP) to healthcare.

“Healthcare is expensive worldwide, and Ghana must prioritize funding to improve access and outcomes,” she stressed.

Dr. Aryeetey’s remarks serve as a call to action for enhanced cancer awareness, early detection, and increased investment in healthcare to support patients and reduce the burden of the disease.